As participants in the Avon Walk for Breast Cancer wound their way through Chicago this week, oncologists and cancer researchers met close by at the 2012 annual meeting of the American Society for Clinical Oncology to discuss the latest research in the field. At the meeting's opening session, American Cancer Society CEO John Seffrin said, "We are at an unprecedented place in our understanding" of cancer, and added that cancer death rates are dropping, and doctors must take the opportunity to keep this trend going by teaching their patients everything they know about preventing cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.